Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

EMA begins early advice pilot to improve pediatric drug development

This article was originally published in SRA

Executive Summary

The European Medicines Agency is offering companies free early advice on the pediatric aspects of drug development, in order to help them make their development programs more efficient and ultimately speed up access to new drugs for children.


Related Content

Parallel EMA-FDA Pediatric Advice On The Cards For Companies